Cardiometabolic disease - biocrates life sciences ag

All posts to the category

Cardiometabolic disease

Cardiometabolic disease is a major public health concern although it is partly preventable and manageable with appropriate lifestyle changes. The term cardiometabolic disease refers to two groups of diseases with common risk factors: cardiovascular diseases such as stroke and heart attack and metabolic disorders such metabolic syndrome and type 2 diabetes.

Leucine – Metabolite of the month

Metabolite of the month is your sneak peek into the world of metabolomics. This month, we look at leucine, an amino acid involved in energy metabolism, autophagy, and more.

Metabolite of the month – Sphingomyelins

Metabolite of the month is your sneak peek into the world of metabolomics. In this month´s article, we took a closer look at sphingomyelins, building blocks of eukaryotic cell membranes, play in cell signaling, growth, and survival.

The 8th Munich Metabolomics Symposium

Recap of the 8th Munich Metabolomics Symposium, November 12th, 2021

Short-term air pollution alters amino acid metabolism

Well-defined exposure to air pollution reveals distinct perturbations of amino acid metabolism

Metabolite of the month – Triglycerides

Metabolite of the month is your sneak peek into the world of metabolomics. In this month´s article, we took a closer look at Triglycerides, complex molecules used ..

Metabolite of the month – Butyric acid

Metabolite of the month is your sneak peek into the world of metabolomics. In this month´s article, we took a closer look at butyric acid, which is one of three common SCFAs in the human gut.

Dyslipidemia contributes to cardiac autonomic neuropathy in type 2 diabetes

Cardiac autonomic neuropathy is linked to perturbations of the lipid metabolism specifically in Type 2 Diabetes.

Metabolism of fatty liver disease and the impact of therapy

New study demonstrates the power of metabolomics in boosting our understanding of fatty liver disease – and possible treatments. Obeticholic acid reverses metabolic changes in NASH.